Search results
Why Moderna Stock Is a No-Brainer Buy Right Now | The Motley Fool
The Motley Fool· 21 hours agoIn 2022, the biotech company generated sales of nearly $18.9 billion, but it expects revenue of only...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Digital Journal· 21 hours agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older ...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
The Sacramento Bee· 21 hours agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID vaccines in adults 50 years and older ...
Moderna’s flu-COVID combo shot hits goal in late-stage trial
Detroit News· 16 hours agoModerna Inc. said its combination flu and COVID shot met the goals of a pivotal late-stage trial,...
Moderna's Combo Flu/Covid Shot Topped Rivals From Sanofi, GSK
Investor's Business Daily· 21 hours agoIn a study of about 8,000 people, Moderna's combination vaccine proved it's not inferior to the...
Ticker: Massachusetts gas prices down 4 cents; Moderna’s COVID-flu combo vaccine has positive...
Boston Herald· 13 hours agoTicker: Massachusetts gas prices down 4 cents; Moderna’s COVID-flu combo vaccine has positive...
Moderna to present combo COVID-flu vaccine to regulators after trial
Scripps News via AOL· 16 hours agoModerna compared the immune response between those who were given mRNA-1083 versus those who were...
Moderna's combo COVID and flu shot offers strong immunity in older adults during late stage trial
ABC7 News· 14 hours agoModerna's combo flu and COVID vaccine provided a strong immune response in older adults, with levels comparable to getting the flu and COVID shots separately ...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 10 hours agoPfizer-BioNTech and Novavax are also working on their own COVID-flu vaccines, but Moderna is the...
Why Moderna Stock Is a No-Brainer Buy Right Now
The Motley Fool via AOL· 21 hours agoCMV is the top infectious cause of birth defects in the U.S. and currently has no approved vaccines. With Merck, Moderna is testing a combination of Merck's ...
